講演情報

[1P-800]Favipiravir as an antiviral drug candidate against Oropouche virus infection

○Cassia Sousa Moraes1,2, Atsuko Inoue1,3, Koshiro Tabata1, Akihito Sato4,5, Joshua Kranrod1,6, Keita Matsuno7,8, Shinji Saito1, Gabriel Gonzalez9, Hirofumi Sawa1,8, Yukari Itakura1 (1. Division of Biological Response Analysis, Institute for Vaccine Research and Development, Hokkaido University., 2. Graduate School of Infectious Diseases, Hokkaido University, Japan., 3. Faculty of Pharmaceutical Science, Graduate School of Life Science, Hokkaido University, Japan., 4. Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University., 5. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., 6. Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University., 7. Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University., 8. One Health Research Center, Hokkaido University, Sapporo, Japan., 9. Division of Research Support, Institute for Vaccine Research and Development, Hokkaido University.)

コメント

コメントの閲覧・投稿にはログインが必要です。ログイン